← All patents

US20230014398A1

Anti-b7-h3 monoclonal antibody and methods of use thereof

University of Texas System

Abstract

Provided herein are agents, such as antibodies, antibody-drug conjugates, or chimeric antigen receptors, that target B7-H3. Methods of treating cancer are provided, comprising administering to a patient in need thereof an effective amount of an B7-H3-targeting agent. The patient may be selected …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
David Piwnica-Worms
Priority date
November 18, 2019
Filing date
November 18, 2020
Publication date
January 19, 2023
Language
en
Metadata fetched
August 29, 2026 00:30